You have 9 free searches left this month | for more free features.

dexamethasone intraocular suspension

Showing 1 - 25 of 4,839

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

DEXYCU 9% Retrospective Study 001

Completed
  • Cataract
  • DEXYCU (dexamethasone intraocular suspension) 9%.
  • Dothan, Alabama
  • +21 more
May 24, 2021

Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy, Intraocular Pressure Trial (Fluorometholone 0.1% Oph Susp,

Not yet recruiting
  • Pseudophakic Bullous Keratopathy
  • +2 more
  • Fluorometholone 0.1% Oph Susp
  • +2 more
  • (no location specified)
Feb 7, 2023

Dry Eye Syndromes Trial in Sycamore (dexamethasone intraocular suspension, 9%, Prednisolone Acetate 1% Oph Susp)

Completed
  • Dry Eye Syndromes
  • dexamethasone intraocular suspension, 9%
  • Prednisolone Acetate 1% Oph Susp
  • Sycamore, Illinois
    Hauser Ross Surgical Center
Jan 31, 2021

Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative Trial (OCS-01)

Not yet recruiting
  • Uveitis Related Cystoid Macular Edema
  • Cystoid Macular Edema, Postoperative
  • (no location specified)
Nov 1, 2022

Cataract Trial in Dayton (Dextenza 0.4Mg Ophthalmic Insert)

Completed
  • Cataract
  • Dextenza 0.4Mg Ophthalmic Insert
  • Dayton, Ohio
    Iworks Laser & Vision Center
Dec 22, 2022

Dry Eye Trial in Hemet, Laguna Hills, Saint Louis (Dexamethasone)

Completed
  • Dry Eye
  • Hemet, California
  • +2 more
Dec 30, 2021

Cataract Surgery, Glaucoma Surgery Trial (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1% Ophthalmic Suspension [PRED

Withdrawn
  • Cataract Surgery
  • Glaucoma Surgery
  • Dextenza 0.4Mg Ophthalmic Insert
  • Prednisolone Acetate 1% Ophthalmic Suspension [PRED FORTE]
  • (no location specified)
Nov 16, 2021

Inflammation, Pain, Postoperative, Trismus Trial in Granada (Dexamethasone 4 Mg/mL Injectable Solution, MethylPREDNISolone 40

Recruiting
  • Inflammation
  • +2 more
  • Dexamethasone 4 Mg/mL Injectable Solution
  • MethylPREDNISolone 40 Mg/mL Injectable Suspension
  • Granada, Spain
    Unai Fernández Martín
Feb 28, 2023

Cataract Trial (Dexamethasone 0.4 MG [Dextenza])

Not yet recruiting
  • Cataract
  • Dexamethasone 0.4 MG [Dextenza]
  • (no location specified)
Nov 22, 2021

Cataract Trial (Dexamethasone 0.4 MG [Dextenza])

Not yet recruiting
  • Cataract
  • Dexamethasone 0.4 MG [Dextenza]
  • (no location specified)
Oct 27, 2021

Intraocular Pressure, Corneal Opacity Trial in Murray (Loteprednol Etabonate 0.5% Oph Gel, Prednisolone Acetate 1% Oph Susp)

Completed
  • Intraocular Pressure
  • Corneal Opacity
  • Loteprednol Etabonate 0.5% Oph Gel
  • Prednisolone Acetate 1% Oph Susp
  • Murray, Utah
    Moran Eye Center - Midvalley Location
May 4, 2021

Cataract Surgery Trial in Kansas City (Omidria, Dextenza (dexamethasone ophthalmic insert) 0.4mg, Dexycu, 9% Intraocular

Unknown status
  • Cataract Surgery
  • Kansas City, Missouri
    Silverstein Eye Centers
Mar 18, 2020

Inflammation Eye, Pain, Postoperative, Cataract Trial in United States (Dexamethasone Ophthalmic Suspension, Vehicle of OCS-01)

Not yet recruiting
  • Inflammation Eye
  • +2 more
  • Dexamethasone Ophthalmic Suspension
  • Vehicle of OCS-01
  • Inglewood, California
  • +11 more
Nov 7, 2023

Acute Adenoviral Conjunctivitis Trial in United States (FST-100 Ophthalmic Suspension, Placebo)

Terminated
  • Acute Adenoviral Conjunctivitis
  • FST-100 Ophthalmic Suspension
  • Placebo
  • Torrance, California
  • +12 more
Aug 22, 2021

Inflammation Corneal, Pain, Postoperative Trial in United States (OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic

Completed
  • Inflammation Corneal
  • Pain, Postoperative
  • OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL
  • Placebo
  • Petaluma, California
  • +3 more
Feb 17, 2022

Bilateral Conjunctivitis (Disorder) Trial in Pompano Beach (Dexamethasone ophthalmic insert 0.4Mg, 0.2% loteprednol etabonate

Completed
  • Bilateral Conjunctivitis (Disorder)
  • Dexamethasone ophthalmic insert 0.4Mg
  • +2 more
  • Pompano Beach, Florida
    Clinical Research Center of Florida
Apr 6, 2022

Acute Otitis Externa Trial in Pago Pago (FST201 (dexamethasone 0.1% with povidone-iodine 1%), Ciprodex (Ciprofloxacin 0.3%;

Completed
  • Acute Otitis Externa
  • FST201 (dexamethasone 0.1% with povidone-iodine 1%)
  • Ciprodex (Ciprofloxacin 0.3%; dexamethasone 0.1% )
  • Pago Pago, American Samoa
    LBJ Tropical Medical Center, Department of Otolaryngology
Jun 9, 2021

Cataract Trial in Vineland (Dexamethasone, Prednisolone Acetate 1% Oph Susp)

Recruiting
  • Cataract
  • Vineland, New Jersey
    Eye Associates of Vineland
Mar 17, 2021

Chronic Suppurative Otitis Media Trial (ciprofloxacin and dexamethasone suspension)

Not yet recruiting
  • Chronic Suppurative Otitis Media
  • ciprofloxacin and dexamethasone suspension
  • (no location specified)
Nov 12, 2021

Acute Otitis Externa Trial in United States (FST-201 (dexamethasone 0.1%) Otic Suspension, ciprofloxacin 0.3%, dexamethasone

Terminated
  • Acute Otitis Externa
  • FST-201 (dexamethasone 0.1%) Otic Suspension
  • ciprofloxacin 0.3%, dexamethasone 0.1%
  • Boynton Beach, Florida
  • +5 more
May 24, 2021

Dry Eye Disease, Cataract Surgery, Ocular Surface Disease Trial (Dextenza 0.4Mg Ophthalmic Insert)

Not yet recruiting
  • Dry Eye Disease
  • +2 more
  • Dextenza 0.4Mg Ophthalmic Insert
  • (no location specified)
Dec 10, 2020

Acute Fungal Otitis Externa Trial in United States (FST-201 (dexamethasone 0.1%) Otic Suspension, Vehicle)

Terminated
  • Acute Fungal Otitis Externa
  • FST-201 (dexamethasone 0.1%) Otic Suspension
  • Vehicle
  • Boynton Beach, Florida
  • +5 more
May 24, 2021

Steroid Ophthalmic Insert Trial (Dextenza 0.4Mg Ophthalmic Insert, Topical Fluorometholone)

Not yet recruiting
  • Steroid Ophthalmic Insert
  • Dextenza 0.4Mg Ophthalmic Insert
  • Topical Fluorometholone
  • (no location specified)
Oct 17, 2022

Acute Otitis Externa Trial in Puerto Rico, United States (Ciprodex®, EXL CDOS (Ciprofloxacin 0.3% and Dexamethasone 0.1%)

Completed
  • Acute Otitis Externa
  • Ciprodex®
  • EXL CDOS (Ciprofloxacin 0.3% and Dexamethasone 0.1%) Sterile Otic Suspension
  • Birmingham, Alabama
  • +47 more
May 27, 2021